Weekly Signal: 27 | BCI Gains, DBS Updates & Policy

Clinical signals, market moves

Author

Ricardo Albornoz
October 04, 2025

Table of Contents

🧠 Weekly Signal

Breakthroughs & Policy Moves

Neurotechnology News | Sep 27–Oct 3, 2025

Let's cut through the noise this week!

This week, we saw a peer-reviewed, minimally invasive 1,024-channel cortical interface demonstrated in humans and a nanoparticle therapy that extends intracortical signal quality. Meanwhile, MRI-native neurosurgical robotics and virtual neurology attracted new capital. In policy, U.S. senators proposed an FTC study on neural data and Belgium expanded nVNS access. Bottom line: safer BCIs, stronger privacy guardrails, and pragmatic market momentum are converging.

🧠 SCIENCE & CLINICAL TRIALS

🟢 Minimally invasive 1,024-channel cortical array shows intraoperative decoding

Published: October 2, 2025

Read more ➡️MassDevice / Nature

Precision Neuroscience reported a thin-film micro-electrocorticography (µECoG) array implanted via a 0.5–0.9 mm “cranial micro-slit” in minipigs and used intraoperatively in five patients. Binary detection of speech onset reached 79.8% accuracy from 4 minutes of training (54 utterances); the same electrodes also delivered sub-millimeter stimulation.

💡 Big Picture: Demonstrates a path to scalable, reversible cortical brain–computer interfaces (BCIs) without craniotomy for mapping and future assistive communication.

🟢 Platelet-inspired nanoparticles improve intracortical microelectrode performance in vivo

Published: September 29, 2025

Read more ➡️ Bioengineer.org / Nature

In rats, weekly systemic dexamethasone-loaded, platelet-inspired nanoparticles improved active-electrode yield by 36% (weeks 1–4) and 82% (weeks 5–8) versus control, and preserved local neuron density (59% vs 21%). Results point to reduced neuroinflammation and blood–brain barrier leakage as mechanisms.

💡 Big Picture: Targeted systemic nanotherapy could extend the useful life of intracortical BCIs and lower failure-driven revision rates.

💼 INDUSTRY & STARTUPS

🟢 AiM Medical Robotics closes $8.1M Series A for MRI-compatible neurosurgery

Published: September 30, 2025

Read more ➡️ MassDevice / AiM Medical Robotics

Funding will support the first human study of AiM’s intraoperative MRI-guided robot aimed at precise device placement and addressing brain shift in functional neurosurgery. The system targets indications like Parkinson’s disease neurostimulation and aims to eliminate patient transfers between OR and imaging suite.

💡 Big Picture: MRI-native robotics could standardize stereotactic workflows and reduce time-to-therapy in hospital neurosurgical programs.

🟢 Neura Health raises $11.4M Series A; first investment from AHA’s Go Red Fund

Published: September 29, 2025

Read more ➡️Neura Health / GlobeNewswire

The virtual neurology clinic will scale nationally, expand memory care, and deepen payer and health-system partnerships; total funding reaches $22M. Neura reports 43,000 patients served and coverage with 40+ plans, positioning for broader specialty access.

💡 Big Picture: Virtual-first neurology is maturing into enterprise partnerships, broadening intake for specialty care and real-world data generation.

🏛️ POLICY & ETHICS

🟢 U.S. senators introduce the MIND Act to direct FTC neural data study

Published: September 29, 2025

S.2925 would require the Federal Trade Commission to study governance of neural data—covering implanted BCIs, wearables, and inferred signals—and report within a year, then annually. The bill tasks FTC and OSTP with guidance for federal agency use.

💡 Big Picture: Lays groundwork for a federal baseline on neural data practices before mass-market neurotech scales.

🟢 Belgium adds reimbursement for gammaCore (nVNS) in cluster headache

Published: September 29, 2025

Read more ➡️ GuruFocus / electroCore

Belgium’s RIZIV/INAMI added long-term reimbursement for gammaCore Sapphire non-invasive vagus nerve stimulation effective Oct 1, 2025, expanding access for cluster headache patients. Decision cites clinical and economic evidence and may influence nearby markets.

💡 Big Picture: Payer recognition of neuromodulation strengthens the case for non-pharmacologic headache care across the EU.

🎯 Community Challenge

Ready to take neurotech to the next level? Share your insights, projects, ideas, our upcoming list of NeuroHacks, or your own groundbreaking work—and watch the inspiration ripple across the community!

How to Participate

  1. Follow HackTheNeuron

    Show us support by following us on X, Instagram and Tik Tok!

  2. Create a Post
    Show us what you’re working on—DIY projects, research breakthroughs, or even your latest neurotech musings.

  3. Use #Neurotech
    This helps your ideas reach fellow enthusiasts and potential collaborators.

  4. Mention @HackTheNeuron
    Tag us directly in your post so we never miss your entry—and we’ll amplify your work across our entire NeuroCircuit community!

Why Join?

  • Boost Your Reach: Tap into a niche but fast-growing community for extra visibility.

  • Build Your Network: Connect with researchers, developers, and curious tinkerers who share your passion.

  • Shape Neurotech’s Future: Your project or insight could spark the next big breakthrough—or inspire someone else’s.

We can’t wait to see your creativity in action! Fire up X, LinkedIn, Facebook, Instagram, or TikTok, and spread the word. Let’s spark innovation together!

🚀Recruit More Neurohackers

Your referrals are the engine that drives our community forward. Share your unique referral link with friends, colleagues, or fellow neurotech enthusiasts—and watch us grow together!

  • Spread the Word: Copy your personal referral link and post it on social, forums, or in emails.

  • Unlock Exclusive Perks: Every friend who subscribes through your link brings you closer to special rewards—insider insights, private Discord access, early project previews, and more.

  • Be the Catalyst: The more you share, the stronger our network becomes. Help us build the ultimate neurotech hub—one referral at a time!

✍️Help Us Improve

Your input is what will make The NeuroCircuit and Hack The Neuron better. Let us know what you’d like more of—and what we can do differently.

  • Share Your Ideas: Tell us which topics, features, or formats you’d love to see next.

  • Spot the Gaps: Let us know if anything’s missing or unclear in our content and community tools.

  • Shape the Experience: Whether it’s new challenges, tutorials, or platform features, your suggestions guide our roadmap.

Reply

or to participate.